Cat. #161696
Anti-B2M monoclonal antibody [GRH1]
Cat. #: 161696
Sub-type: Primary antibody
Availability: 3-4 weeks
Target: Beta-2-microglobulin
Class: Monoclonal
Application: FACS; IHC; ELISA; WB
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Francisco Ruíz-Cabello Osuna, Miguel Ángel López-Nevot, Federico Garrido Torres-Puchol
Institute: Virgen de las Nieves University Hospital, The Andalusian Health Service
Primary Citation: Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-B2M monoclonal antibody [GRH1]
- Cancer: Blood cancer
- Research fields: Cancer
- Clone: GRH1
- Tool sub type: Primary antibody
- Class: Monoclonal
- Molecular weight: 12 kDa
- Reactivity: Human
- Host: Mouse
- Application: FACS; IHC; ELISA; WB
- Description: Beta-2-microglobulin (B2M) is part of the histocompatibility antigens class I, HLA-ABC, forming a non-covalently bound complex with them. It is expressed in most cells in the body, with very low or undetectable levels in neurons and spermatozoa.
- Immunogen: B-ALL cells
- Isotype: IgG1
- Recommended controls: B-Lymphocytes, macrophages
Target Details
- Target: Beta-2-microglobulin
- Target alternate names: B2M
- Molecular weight: 12 kDa
Applications
- Application: FACS; IHC; ELISA; WB
Handling
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Dry ice
References
- Perea et al. 2017. Int J Cancer. 140(4):888-899. PMID: 27785783
- B del Campo. 2014. Int J Cancer. 134(1):102-113. PMID: 23784959
